Related by context. All words. (Click for frequent words.) 72 Archexin 72 alvespimycin 71 Panzem R 71 Allovectin 7 71 OvaRex R 71 Asentar 71 TOCOSOL Paclitaxel 71 OvaRex ® MAb 70 otelixizumab 70 IMA# 70 Panzem R NCD 70 deforolimus 70 HepeX B 69 torezolid phosphate 69 MGCD# [001] 69 PANVAC VF 69 lorvotuzumab mertansine 69 oral prodrug 69 ARIKACE ™ 69 elotuzumab 69 phase IIb clinical 69 Cloretazine ® 69 Alzhemed TM 69 atacicept 68 Hematide ™ 68 Onconase 68 TBC# 68 intranasal insulin product 68 compound INCB# 68 tramiprosate Alzhemed TM 68 INCB# [001] 68 apricitabine ATC 68 HuMax CD4 68 ganetespib 68 Evoltra ® 68 ELACYT 68 ASONEP 68 JAK inhibitor 68 Xcytrin R 68 Annamycin 68 metaglidasen 68 lintuzumab SGN 68 Fodosine 68 voreloxin 68 liposomal formulation 68 HuLuc# 68 Bicifadine 68 L BLP# 68 HGS ETR2 68 Allovectin 7 R 68 PLK1 SNALP 68 tanespimycin 67 UPLYSO 67 obatoclax 67 mitogen activated ERK kinase 67 YONDELIS 67 candidate deforolimus 67 investigational humanized monoclonal antibody 67 ularitide 67 Amrubicin 67 Xanafide 67 HEPLISAV ™ 67 ridaforolimus 67 virus HCV protease inhibitor 67 MAXY alpha 67 GVAX ® 67 Troxatyl 67 romidepsin 67 Plicera 67 Cloretazine 67 #D#C# 67 PEG PAL 67 Phase #b/#a 67 Actimmune ® 67 phase IIa clinical 67 Azedra 67 phase IIb trial 67 Shigamabs ® 67 ONCONASE R 67 ONCONASE 67 Phase #b/#a clinical 67 oral taxane 67 tezampanel NGX# 67 rhIGF-I/rhIGFBP-3 67 candidate brentuximab vedotin 67 BRILINTA 67 Fibrillex TM 67 TELINTRA 67 MAXY VII 67 SinuNase TM 66 ZADAXIN ® 66 registrational 66 forodesine 66 radiation sensitizer 66 brentuximab vedotin SGN 66 rNAPc2 66 FOLOTYN ® 66 Ceflatonin R 66 lomitapide 66 Chemophase 66 amrubicin 66 Aurexis 66 MAXY G# 66 ATL# [001] 66 entinostat 66 PRTX 66 rALLy clinical trial 66 leading oral taxane 66 PRT# 66 Exherin TM 66 Cloretazine R VNP#M 66 Apoptone 66 HQK 66 FavId 66 AAG geldanamycin analog 66 ponatinib 66 2 methoxyestradiol 66 confirmatory Phase III 66 KIACTA ™ 66 XP# XP# 66 evaluating tivozanib 66 Icatibant 66 KNS # 66 DPX Survivac 66 Maxy G# 66 glucokinase activator 66 Troxatyl TM 66 elacytarabine 66 RhuDex ® 66 XL# anticancer compounds 66 candidate TNFerade biologic 66 EGS# 66 Dacogen injection 66 RIGScan CR 66 talactoferrin 66 MAGE A3 ASCI 66 acyclovir Lauriad R 66 enzastaurin 66 CoFactor 66 ruxolitinib 66 Bezielle 66 drug ISA# 66 Personalized Immunotherapy 66 OMAPRO 66 therapeutic monoclonal antibody 66 XL# XL# XL# XL# 65 IMC #B 65 Phase 2a clinical trials 65 PDE4 inhibitor 65 Vectibix panitumumab 65 LymphoStat B 65 Traficet EN 65 XmAb# 65 ixabepilone 65 TRO# 65 bardoxolone 65 Cinryze ™ 65 Kosan dependence 65 SUCCEED trial 65 anticancer compound 65 THR beta agonist 65 docetaxel Taxotere R 65 Fx #A 65 ALN PCS 65 Genz # 65 midstage trials 65 Insegia 65 Tarceva TM 65 GED aPC 65 HCV protease inhibitors 65 histamine dihydrochloride 65 Neo Kidney Augment ™ 65 MAA submission 65 Veronate 65 IMiDs R 65 Difimicin 65 pharmacokinetic PK study 65 oxaliplatin Eloxatin 65 TOCOSOL 65 tubulin inhibitor 65 Spiegelmer ® 65 LibiGel ® 65 Aplidin 65 MNTX 65 Amplimexon 65 SNT MC# 65 HCD# [002] 65 PHX# 65 PrevOnco 65 PREOS 65 Marqibo TM 65 OHR/AVR# 65 PREOS R 65 cathepsin K inhibitor 65 KRYSTEXXA TM pegloticase 65 VALOR trial 65 Phase IIb clinical trials 65 axitinib 65 motexafin gadolinium Injection 65 sapacitabine CYC# 65 Zemplar Capsules 65 targeted radiotherapeutic 65 AP# [003] 65 Phase Ib II 65 TPI ASM8 65 R#/MEM # 65 PEG SN# 65 Surfaxin LS 65 Urocidin 65 HGS# 65 Pimavanserin 65 MKC# MT 65 Azedra TM 65 IRX 2 65 RSR# 65 Phase 1a clinical 65 EndoTAG TM -1 65 tiapamil 65 Uvidem 65 MGN# 65 Benlysta belimumab 65 AEG# 65 budiodarone 65 Rhucin R 65 PROVENGE sipuleucel T 65 Civacir 65 candidate CRLX# 65 PDE# inhibitors 65 pralatrexate 65 SinuNase ™ 65 IMC A# 65 IV APAP 65 orally administered inhibitor 65 oral picoplatin 65 Memryte 65 non nucleoside HCV 65 reslizumab 65 Tyrima 64 Aryplase 64 OncoVEX GM CSF 64 IL# PE#QQR 64 Soliris TM eculizumab 64 Neuradiab 64 Campath ® 64 Phase 1b trial 64 Solazed 64 successfully commercialize Iluvien 64 Temsirolimus 64 Stimuvax R 64 CRMD# 64 refractory chronic lymphocytic 64 ZOLINZA 64 THALOMID 64 Factor VIIa 64 Androxal TM 64 custirsen 64 PI3K/Akt pathway inhibitor 64 molecular imaging radiopharmaceutical 64 HCV polymerase inhibitors 64 candidate AQ4N 64 Specifid 64 investigational monoclonal antibody 64 dirucotide 64 novel VDA molecule 64 Onco TCS 64 Pyridorin 64 acetonide FA 64 OncoVEX 64 personalized immunotherapy 64 Cloretazine R 64 polysaccharide polymer 64 ALN TTR 64 Marqibo 64 Nanobody 64 CCR5 antagonist 64 Voreloxin 64 Mipomersen 64 Diamyd ® 64 TACI Ig 64 Ambrisentan 64 FM VP4 64 LEP ETU 64 CINQUIL 64 Synavive ™ 64 indibulin 64 Zerenex ™ 64 oral ridaforolimus 64 initiated Phase 1b 64 inhaled liposomal ciprofloxacin 64 Pruvel 64 ApoB SNALP 64 CR# vcMMAE 64 LEVADEX ™ 64 tramiprosate ALZHEMED TM 64 vascular disrupting agent 64 DXL# 64 trastuzumab DM1 T DM1 64 subcutaneous formulation 64 ulimorelin 64 CDP# 64 isoform selective 64 dimebon 64 JAK2 inhibitor 64 Quinamed 64 dacetuzumab 64 Anticalin R 64 StaphVAX 64 dirucotide MBP# 64 orally bioavailable 64 Aganocide 64 teplizumab 64 Phase IIIb clinical 64 TOCOSOL Camptothecin 64 Allovectin 7 ® 64 Synavive 64 Virulizin R 64 EVIZON TM squalamine lactate 64 Intravenous CP 64 KRN# 64 sitaxsentan 64 YONDELIS R 64 BAY #-# 64 eniluracil 64 elvucitabine 64 small molecule tyrosine 64 alvimopan 64 SAR# [004] 64 BLA filing 64 forodesine hydrochloride 64 Phase Ib 64 MAb therapy 64 Phase 1b clinical 64 Peginterferon alfa 2b 64 Omacetaxine 64 CCR9 antagonist 64 NP2 Enkephalin 64 inhaled AAT 64 GSK# [002] 64 VNP#M 64 Crofelemer budesonide foam 64 ZK EPO 64 RELOVAIR ™ 64 Phenoptin 64 tamibarotene 64 cardio renal 64 PLAVIX ® 64 Proellex TM 64 seliciclib CYC# 64 MKC# MKC# PP 64 Aflibercept 64 Symadex 64 Viramidine 64 omacetaxine 64 GLP toxicology studies 64 Glybera 64 TAFA# 64 ISTODAX 64 faropenem 64 CBLC# 64 DOS# 64 BrachySil TM 64 Epothilones 64 R#/MEM 64 dextofisopam 64 Phase IIb trials 64 LibiGel ® testosterone gel 64 Unit Dose Budesonide 64 Revlimid lenalidomide 64 glufosfamide 64 lintuzumab 64 Telintra 64 midstage clinical 64 Tykerb lapatinib 64 NEUMUNE 64 riociguat 64 belinostat 64 Acetavance TM intravenous acetaminophen 64 pan HDAC inhibitor 63 Phase Ib study 63 LymphoStat B TM 63 novel histone deacetylase 63 Cetrorelix 63 Protexia ® 63 Evoltra R 63 CEQ# 63 tezampanel 63 OMAPRO ™ 63 Liprostin 63 treats acute lymphoblastic 63 TRISENOX 63 celgosivir 63 Gemzar ® 63 StaphVAX R 63 AQ4N 63 Sphingomab TM 63 Myocet 63 CTAP# Capsules 63 Adnectin 63 IMPDH inhibitor 63 Hematide TM 63 STEDESA 63 ProLindac TM 63 ATL# [002] 63 TELCYTA 63 danoprevir 63 Ereska 63 Plenaxis TM 63 Hedgehog Pathway Inhibitor 63 picoplatin 63 Omigard 63 Phase IIa clinical trials 63 dalbavancin 63 bicifadine 63 dexanabinol 63 panitumumab Vectibix 63 PSN# [002] 63 ENRICH trial 63 Phase 2b clinical trials 63 Reverset 63 P#X# antagonist 63 PDX pralatrexate 63 LibiGel testosterone gel 63 BioNumerik 63 ThermoDox ® clinical 63 solanezumab 63 MEK inhibitor RDEA# 63 baminercept 63 Vidaza R 63 lumiliximab 63 ocrelizumab 63 #ME# 63 MGd 63 Alnylam #x# 63 Azixa 63 CYT# vascular disrupting 63 SYGNIS 63 oral deforolimus 63 Genasense ® oblimersen 63 candidate epratuzumab 63 candidate XP# 63 LymphoStat B belimumab 63 Tovaxin ® 63 FOLOTYN 63 Virulizin ® 63 Corlux 63 apoptosis inducer 63 Bioral Amphotericin B 63 Allovectin 7 r 63 CMV vaccine 63 Canvaxin TM 63 miRNA therapeutics 63 albinterferon alfa 2b 63 TNFerade ™ 63 highly purified pasteurized 63 mertansine 63 including eniluracil ADH 63 CD# CEA 63 Zenvia ™ 63 Exelixis compounds 63 cobiprostone 63 HEPLISAV TM 63 Harry Palmin President 63 Angiocept 63 Trofex TM 63 synthetic retinoid 63 hepatitis C protease inhibitor 63 Rebif ® 63 phase IIb 63 Thiovir 63 MYDICAR ® 63 MEK inhibitors 63 Zerenex 63 rALLy trial 63 CYT# potent vascular disrupting 63 lapatinib Tykerb 63 Hematide ™ peginesatide 63 Amigal 63 ROTATEQ 63 interferon gamma 1b 63 Lenocta 63 HGS ETR1 63 epothilone 63 proteasome inhibitor 63 multicenter Phase II 63 palifosfamide Zymafos TM 63 REMINYL ® 63 PrevOnco ™ 63 Prestara 63 adipiplon 63 XYOTAX TM 63 Nanobody ® 63 LibiGel transdermal testosterone gel 63 pertuzumab 63 vinca alkaloid 63 ELND# 63 receptor tyrosine kinase inhibitor 63 NVA# 63 ATL/TV# 63 Presents Preclinical 63 Sulonex TM 63 vemurafenib 63 TOLAMBA 63 MOZOBIL 63 sapacitabine 63 phase IIa 63 novel oral anticoagulant 63 PF # [002] 63 UVIDEM 63 DermaVir Patch 63 Viprinex TM 63 OncoVex 63 candidates bavituximab 63 registrational trial 63 Pegloticase 63 EndoTAGTM 1 63 Carfilzomib 63 teduglutide 63 PROVENGE ® 63 palifosfamide 63 Ketotransdel 63 Oglemilast 63 Shigamabs R 63 Vascular Wrap TM 63 XL# XL# 63 sodium Injection 63 aleglitazar 63 oncolytic virus therapies 63 HuMax TAC 63 midstage studies 63 Zemiva TM 63 Deforolimus 63 Valortim 63 sorafenib Nexavar 63 pradefovir 63 Exherin 63 CINTREDEKIN BESUDOTOX 63 NeuroSTAT ® 63 Neo Kidney Augment 63 Telatinib 63 Harbor BioSciences 63 phase Ib 63 histone deacetylase HDAC inhibitor 63 Perifosine 63 HCV protease 63 investigational antiplatelet agent 63 Theratope 63 Genasense R oblimersen 63 Belinostat 63 Urocortin 2 63 Zavesca r 63 Arranon 63 GVAX R 63 Nexavar ® 63 AEGR 63 severe hypercholesterolemia 63 orBec R oral beclomethasone 63 TRACON Pharmaceuticals 63 telaprevir VX 63 oral methylnaltrexone 63 Prednisporin TM 63 refractory gout 63 EOquin TM 63 DCVax R 63 NV1FGF 63 Trofex 63 Phase #/#a 63 Initiates Phase II 63 initiated Phase Ib 63 IMiDs 62 ASONEP TM 62 Ceflatonin 62 immunosuppressant therapies 62 Anticalin 62 Proxinium TM 62 triphendiol 62 GSK '# 62 Anturol TM 62 Anturol ® 62 hoFH 62 Octreolin 62 tecarfarin 62 Tesmilifene 62 alemtuzumab Campath 62 MyVax personalized immunotherapy 62 PORxin TM 62 PEG Interferon lambda 62 ELADUR 62 volociximab 62 Orencia abatacept 62 LEUKINE 62 oral talactoferrin 62 HuMax CD# 62 Amoxicillin PULSYS Phase III 62 Canvaxin 62 NPC 1C 62 cancer immunotherapies 62 StemEx R 62 EOquin 62 FOLFOX6 chemotherapy regimen 62 IIa trial 62 novel emulsion formulation 62 R sorafenib tablets 62 liprotamase 62 BrachySil 62 Oracea TM 62 BENLYSTA TM 62 PSMA ADC 62 neratinib 62 ALN TTR# 62 MT#/MEDI-# 62 Laquinimod 62 Aviptadil 62 Pafuramidine 62 dextromethorphan quinidine 62 CRLX# 62 Phase 2a trial 62 TELINTRA R 62 Phase 2b clinical 62 rPA anthrax vaccine 62 oxymorphone ER 62 methylnaltrexone 62 Elagolix 62 Lixivaptan 62 Tocosol Paclitaxel 62 cystinosis patients 62 motesanib 62 Vegenics 62 Plenaxis R 62 Protexia R 62 MCSP respectively 62 Elotuzumab 62 Neulasta R 62 OXi# 62 paclitaxel Taxol ® 62 generation purine nucleoside 62 oxypurinol 62 personalized cellular immunotherapy 62 induced macular edema 62 Junovan 62 Panzem 62 Triapine R 62 romidepsin novel 62 Firazyr 62 GW# [003] 62 Hsp# Inhibitor 62 Cimzia TM 62 PROSTVAC TM 62 delivers fluocinolone acetonide FA 62 Trastuzumab DM1 62 MDV# 62 Abiraterone acetate 62 please visit http:/www.sunesis.com 62 muraglitazar 62 demonstrated antitumor activity 62 RAPTIVA 62 ORENCIA R 62 Panzem ® 62 IMiDs ® compound 62 orBec 62 PSN# [001] 62 dasatinib Sprycel ® 62 tivozanib 62 PGL# 62 Phase III LibiGel 62 Onalta ™ 62 CB2 selective receptor agonist 62 investigational hepatitis C 62 hypoxia activated prodrug 62 Glybera R 62 Lupuzor 62 histone deacetylase inhibitor 62 drug figitumumab 62 nicotinic alpha 7 62 Æterna Zentaris 62 fusion enhancers 62 clinical trials dacetuzumab SGN 62 Nuvion 62 Solazed TM 62 HspE7 62 Lu AA# 62 Zybrestat 62 schizophrenia CIAS 62 Seliciclib 62 nalbuphine ER 62 ProMune 62 Tesetaxel 62 pomalidomide 62 Triolex 62 Initiates Phase III 62 Ceplene TM 62 Linjeta TM 62 APEX PD 62 ospemifene 62 immune modulating 62 Clolar ® 62 GMX# 62 thymalfasin 62 oral isotype selective HDAC 62 Vivecon 62 Xeloda ® 62 Selective Electrochemical Tumor Ablation 62 AdhTAP 62 DP b# 62 VitiGam 62 GALNS 62 Evoltra TM 62 Nasdaq VRTX 62 Targretin capsules 62 brostallicin 62 Daclizumab 62 preclinical efficacy 62 Phase Ib clinical 62 omecamtiv mecarbil 62 relapsed MM 62 generic Copaxone 62 Vilazodone 62 rindopepimut 62 BRAF inhibitor 62 non nucleoside inhibitor 62 BiovaxID TM 62 ISIS # 62 Ceplene histamine dihydrochloride 62 phase 2a 62 Curaxin CBLC# 62 Muraglitazar 62 Pirfenidone 62 tesetaxel 62 histone deacetylase HDAC 62 BARACLUDE R 62 incyclinide 62 Omthera 62 Zalypsis 62 paclitaxel poliglumex 62 fosbretabulin 62 JOULFERON 62 vilazodone 62 HIV integrase inhibitors 62 favorable pharmacokinetic profile 62 Hyphanox 62 daclizumab 62 tremelimumab 62 tafamidis 62 Stedivaze 62 Ophena TM 62 class mGluR5 inhibitor 62 platforms GVAX 62 AzaSite Plus 62 immunotherapeutic vaccine 62 epigenetic therapies 62 Tyzeka Sebivo 62 metastatic sarcomas 62 Nasulin 62 candidate Puricase 62 TYZEKA 62 CCX# 62 DCCR 62 Orphan Drug designations 62 BENLYSTA ® 62 macitentan 62 Triapine 62 PNP inhibitor 62 preclinically 62 eprotirome 62 Prednisporin 62 REG1 62 generation PNP inhibitor 62 omacetaxine mepesuccinate 62 HGS ETR1 mapatumumab 62 candidate REP# 62 diabetic neuropathic pain 62 maximally tolerated dose 62 IND submission 62 atrasentan 62 LE SN# 62 Zalbin 62 MBP# [001] 62 gepirone ER 62 mapatumumab 62 Cerovive 62 Pralatrexate 62 Catena ® 62 PXD# 62 aplindore 62 GRN# 62 Xerecept 62 Golimumab 62 Captisol enabled 62 Phase 2a clinical 62 Prodarsan R 62 Phase Ib clinical trials 62 ENMD # 62 EDEMA3 62 phase III isavuconazole 61 novel therapeutic antibodies 61 DP VPA 61 HepeX B TM 61 Serdaxin 61 Phase III TRIST 61 HCV protease inhibitor 61 Alocrest 61 Dextofisopam 61 Locteron ® 61 IMiDs ® 61 BENLYSTA 61 telomerase inhibitor drug 61 IAP inhibitor 61 oral isoform selective HDAC 61 albiglutide 61 sulodexide 61 Squalamine 61 ILUVIEN ® 61 RLY# 61 tesmilifene 61 MoxDuo IR 61 Tovaxin TM 61 huN# DM1 61 Spiro Rombotis President 61 Vernakalant 61 oritavancin 61 orBec ® oral beclomethasone 61 6R BH4 61 vidofludimus 61 BCX# 61 drug GAP #B# 61 selective estrogen receptor modulator 61 huC# DM4 61 Cinryze TM 61 HuMax EGFr 61 phase IIb study 61 oral antiviral 61 thalidomide Thalomid 61 oral Factor Xa 61 Maribavir 61 Sunesis Pharmaceuticals 61 Anthim 61 sargramostim 61 Pradefovir 61 tramiprosate 61 CA4P 61 ZEFTERA TM Zevtera TM 61 Vicriviroc 61 confirmatory pivotal 61 oral salmon calcitonin 61 evaluating Xcytrin 61 registrational trials 61 PRIMO CABG2 61 EnzymeRx 61 CAMPATH 61 samalizumab 61 ARISE Phase III 61 Phase IIB 61 ticagrelor Brilinta 61 REMOXY ® 61 compound perifosine 61 trastuzumab DM1 61 Rhucin ® 61 Dyloject TM 61 Phase IIa clinical 61 r hGH 61 SILENOR 61 Neurodex 61 bortezomib Velcade 61 SERMs 61 HFA MDI 61 Generx TM 61 Eligard R 61 Iloperidone 61 Thalomid ® 61 PROSTVAC VF 61 Androxal ® 61 GAMMAGARD 61 AERx iDMS 61 Phase Ib IIa 61 metastatic HRPC 61 SUTENT ® 61 Restanza 61 Phase 2b study 61 Albugon 61 alkylating agent 61 BZL# 61 basal insulin analogue 61 SILENOR TM 61 casopitant 61 antibody MAb 61 ICA # 61 Lisofylline LSF 61 Nasdaq PGNX today 61 CONBRIZA 61 Entereg R 61 PRECISE Trial 61 PD LID 61 SPRYCEL ® 61 XL# XL# XL# 61 docetaxel Taxotere ® 61 MOVIPREP R 61 Phase IIa trials 61 Soliris eculizumab 61 zanolimumab 61 REMUNE R 61 confirmatory Phase 3 61 includes TOLAMBA TM 61 Hybridon 61 FluINsure 61 Omnitarg 61 Sanofi Aventis Taxotere 61 please visit www.medicinova.com 61 please visit www.advaxis.com 61 Cardio Vascu Grow 61 ThermoDox R 61 Viprinex 61 SCIB1 61 OncoGel 61 small molecule Hedgehog 61 ThGRF 61 Cinquil 61 nucleoside analogs 61 recombinant subunit vaccine 61 Phase #/#a trial 61 NeuroVax TM 61 investigational HCV polymerase 61 marketed pegylated interferons 61 Junovan TM 61 pegylated interferons 61 DIFICID ™ 61 Targeted Chemotherapy 61 regorafenib 61 non alcoholic steatohepatitis 61 Iluvien ® 61 recombinant biopharmaceutical 61 trastuzumab Herceptin R 61 ambrisentan 61 Ocrelizumab 61 HCV nucleoside polymerase inhibitors 61 Achieves Primary Endpoint 61 BLA submission 61 OMP #R# 61 thetreatment 61 Octreotide 61 SparVax 61 brivaracetam 61 novel anticancer 61 telomerase therapeutic 61 elinogrel 61 MVA BN R 61 MEPACT 61 taribavirin 61 antiangiogenic agent 61 ongoing Phase IIIb 61 refractory Hodgkin lymphoma 61 Diamyd R 61 intranasal formulation 61 HCV antiviral 61 novel synthetic PEGylated 61 rasagiline tablets 61 Tamibarotene 61 ALN VSP 61 Cintredekin Besudotox 61 LEVADEX TM 61 Vitaxin 61 Nabi HB Intravenous 61 sunitinib malate 61 TRAIL receptor antibodies 61 Genentech Roche 61 kidney urologic 61 Velcade bortezomib 61 Mpex 61 phase IIb III 61 Veronate R 61 REOLYSIN ® 61 AzaSite TM 61 galiximab 61 dimebon latrepirdine 61 Fludara ® 61 MyVax R 61 ARIKACE 61 multi kinase inhibitor 61 TRX1 61 compound AEOL # 61 Vidofludimus 61 Alvesco R 61 AVN# [001] 61 Nicole Onetto MD 61 personalized dendritic cell 61 Initiates Phase 2b 61 OvaRex 61 novel DACH platinum 61 hormone LHRH antagonist 61 Genasense ® 61 Akt inhibitor 61 Oral NKTR 61 FUSILEV ® 61 bardoxolone methyl 61 chemotherapy induced neutropenia 61 cMET inhibitor 61 Genentech Rituxan 61 TroVax 61 sodium glucose transporter 61 Asentar TM 61 RANK Ligand inhibitor